The BioInsights Podcast
By BioInsights
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by BioInsights
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 44
Description
The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.
| Episode | Date |
|---|---|
|
Gene therapy is having a monumental year: how can the industry keep up with supply?
|
Apr 04, 2024 |
|
A deep dive in to generative AI applications in I-O
|
Mar 18, 2024 |
|
Developing novel radioimmunotherapy combinations for lung cancer treatment
|
Mar 12, 2024 |
|
Focusing on the fundamentals: what do and don’t we know about mRNA delivery?
|
Mar 11, 2024 |
|
Navigating genomics and transcriptomics in the immuno-oncology space
|
Mar 01, 2024 |
|
Avian influenza and the risk of pandemic
|
Feb 27, 2024 |
|
Exploring the landscape of novel targets & pathways in immuno-oncology
|
Dec 04, 2023 |
|
Multiomics integration: advancing pediatric cancer immunotherapy
|
Nov 02, 2023 |
|
Building with the patient in mind: designing a state-of-the-art facility for viral vector manufacturing
|
Oct 10, 2023 |
|
Can AAV continue to deliver the promise of gene therapy?
|
Sep 13, 2023 |
|
Expanding the potential of in vivo cell therapy with tLNP-RNAs (targeted lipid nanoparticle-RNA)
|
Aug 30, 2023 |
|
Investing long-term in the cell & gene therapies of the future
|
Aug 22, 2023 |
|
Happy medium: considerations in scaling cell culture media strategies
|
Aug 16, 2023 |
|
Applying multiomics to novel target discovery in immuno-oncology
|
Aug 08, 2023 |
|
Modernizing cell therapy manufacturing to reduce vein-to-vein times
|
Jul 26, 2023 |
|
Inducing innate immune responses with particulate adjuvants
|
Jul 26, 2023 |
|
Navigating the complexities of biodistribution, transgene expression & vector shedding in gene therapy development
|
Jun 09, 2023 |
|
Non-viral methods for ex vivo cell & gene therapy: is the future non-viral?
|
May 31, 2023 |
|
Solving challenges in cell therapy clinical trials & effectively delivering complex studies in advanced therapeutics
|
Apr 17, 2023 |
|
Shear ignorance? Think again: breaking the perception of shear within viral vector manufacturing
|
Apr 06, 2023 |
|
Challenges in cryogenic storage containers for cell and gene therapy
|
Mar 22, 2023 |
|
Maximizing Efficiency and Flexibility in Viral Vector Manufacturing Scale-up
|
Mar 02, 2023 |
|
Improvement of viral vector purification using Mustang Q membrane chromatography
|
Dec 13, 2022 |
|
Shear ignorance? Think again: breaking the perception of shear within viral vector manufacturing
|
Nov 09, 2022 |
|
CAR-T cells: from cancer to autoimmunity
|
Oct 12, 2022 |
|
Tales, tips & teachable moments from applications support veterans
|
Oct 11, 2022 |
|
Access to vaccines: how can we leverage technology innovations to achieve greater vaccine equity?
|
Sep 30, 2022 |
|
De-risk & accelerate the drug development process for gene therapy
|
Sep 29, 2022 |
|
Working Together to Safely Advance Cell & Gene Therapies
|
Sep 27, 2022 |
|
Learning from pediatric CAR-T development: insights from manufacturing unique patient doses
|
Sep 26, 2022 |
|
Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take us
|
Sep 12, 2022 |
|
Making the switch from autologous to allogeneic cell therapy
|
Sep 09, 2022 |
|
Accelerating cures: funding stem cell innovation & ideas in an evolving cell therapy space
|
Sep 05, 2022 |
|
Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take us
|
Aug 16, 2022 |
|
Achieving better AAV vector productivity and product quality
|
Aug 05, 2022 |
|
Partnering in life sciences: what is the ‘secret sauce’ for success? PART 2
|
Jul 25, 2022 |
|
Partnering in life sciences: what is the secret sauce for success? PART 1: The Big Pharma perspective
|
Jul 18, 2022 |
|
Where will tomorrow’s workforce come from? PART 3: Innovation in staff sourcing, training and retention - what works and what doesn’t?
|
Jun 20, 2022 |
|
Where will tomorrow’s workforce come from? PART 4: Who are tomorrow’s cell and gene therapy workers?
|
Jun 20, 2022 |
|
Where will tomorrow’s workforce come from? PART 2: How is the educational system responding, and how can the cell and gene therapy community at large help?
|
Jun 07, 2022 |
|
Where will tomorrow’s workforce come from? PART1: Framing the issue
|
Jun 07, 2022 |
|
The quest for the Holy Grail in AAV chromatography: empty–full separation
|
May 25, 2022 |
|
Residual DNA testing in viral vector manufacture: exploring the challenges and solutions
|
May 19, 2022 |
|
Precisely for CGT: automating aseptic filling for lowest volumes
|
May 10, 2022 |